Unnatural Products
Santa Cruz, US · Founded 2016 · Delaware corporation · 14 known investors
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets. The company focuses on expanding its pipeline of novel therapeutic medicines by leveraging macrocycle chemistry and pharmacokinetics.
Founders & leadership
CP
Cameron PyeCo-Founder & CEO
JS
Joshua SchwochertCo-Founder & CSO
VB
Vasudev BaileyDirector
Investors · 14
Abstract VenturesSan Francisco · $100K – $1M
Artis VenturesSan Francisco · $50K – $25Mvia Vasudev Bailey · board
Asset Management CompanyMenlo Park · $500K – $2M
Better Ventures Central LlcOakland · $500K – $1.5M
Blue Bear VenturesSan Francisco · $100K – $400K
Droia VenturesLeuven · $540K
First Spark Ventures, LlcMenlo Park
LongeVCWashington D.C.
Newbury Venturesvia Brent MacDonald · inferred
Rising TidePacifica
The Venture CollectiveMiami Beach · $100K – $2M
WingPalo Alto · $200K – $20M
AbstractreportedSan Francisco · $250K – $750K
Merck Global Health Innovation FundreportedRahway
Reported raises · per SEC filings
Form D private placements▶$25MraisedDec 2023 · 25 investors · BiotechnologyRule 506(b)
▶$25MraisedDec 2023 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vasudev BaileyDirector
- Joshua SchwochertExecutive Officer
- Cameron PyeExecutive Officer, Director
- Prem TumkositDirector
- Offering amount
- $32.7M
- Amount sold
- $25M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedSep 2019 · 11 investors · BiotechnologyRule 506(b)
▶$5.1MraisedSep 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cameron PyeExecutive Officer, Director
- Joshua SchwochertExecutive Officer, Director
- Vasudev BaileyDirector
- Offering amount
- $7.3M
- Amount sold
- $5.1M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Unnatural Products has built its expertise in developing macrocyclic peptides. It had already landed four major partnerships before raising its series B in Marchbiotechtv.com · 2026
- Macrocyclic Peptide Startup Unnatural Products Raises $45M Series B After $3.5B in Pharma Dealsbiopharmatrend.com · 2026
- Unnatural Products lands $45m to drug the undruggablelongevity.technology · 2026
- Unnatural Products gets $45M to test decadelong work on macrocyclic peptidesendpoints.news · 2026
- Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeuticsfinance.yahoo.com · 2026
- Unnatural Products Raises $32M in Series A Fundingfinsmes.com · 2023